BRPI0916228A2 - methods and systems for evaluating memory agents - Google Patents

methods and systems for evaluating memory agents

Info

Publication number
BRPI0916228A2
BRPI0916228A2 BRPI0916228A BRPI0916228A BRPI0916228A2 BR PI0916228 A2 BRPI0916228 A2 BR PI0916228A2 BR PI0916228 A BRPI0916228 A BR PI0916228A BR PI0916228 A BRPI0916228 A BR PI0916228A BR PI0916228 A2 BRPI0916228 A2 BR PI0916228A2
Authority
BR
Brazil
Prior art keywords
systems
methods
memory agents
evaluating memory
evaluating
Prior art date
Application number
BRPI0916228A
Other languages
Portuguese (pt)
Inventor
Lila Davachi
Timothy Tully
Original Assignee
Dart Neuroscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dart Neuroscience Llc filed Critical Dart Neuroscience Llc
Publication of BRPI0916228A2 publication Critical patent/BRPI0916228A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
BRPI0916228A 2008-07-18 2009-07-17 methods and systems for evaluating memory agents BRPI0916228A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8194508P 2008-07-18 2008-07-18
PCT/US2009/051082 WO2010009453A1 (en) 2008-07-18 2009-07-17 Methods and systems for evaluating memory agents

Publications (1)

Publication Number Publication Date
BRPI0916228A2 true BRPI0916228A2 (en) 2015-11-03

Family

ID=41550744

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916228A BRPI0916228A2 (en) 2008-07-18 2009-07-17 methods and systems for evaluating memory agents

Country Status (11)

Country Link
EP (1) EP2313098A4 (en)
JP (1) JP5789511B2 (en)
KR (1) KR20110049801A (en)
CN (1) CN102143749A (en)
AU (1) AU2009270697A1 (en)
BR (1) BRPI0916228A2 (en)
CA (1) CA2730940A1 (en)
IL (1) IL210696A (en)
MX (1) MX2011000652A (en)
SG (1) SG195572A1 (en)
WO (1) WO2010009453A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277842B1 (en) 2012-01-20 2012-10-02 Dart Neuroscience (Cayman) Ltd. Enteric-coated HT-2157 compositions and methods of their use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
EP1161525A2 (en) * 1999-03-12 2001-12-12 Brown University Research Foundation Methods and compositions for regulating memory consolidation
ES2323940T3 (en) * 2000-05-01 2009-07-28 Accera, Inc. USE OF MEDIUM CHAIN TRIGLICERIDS FOR THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE.
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
JP2002020291A (en) * 2000-06-30 2002-01-23 Sumitomo Pharmaceut Co Ltd Therapeutic agent for cognitive dysfunction
WO2002013867A2 (en) * 2000-08-10 2002-02-21 Cold Spring Harbor Laboratory Augmented cognitive training
US20040224316A1 (en) * 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
EP1551855B1 (en) * 2002-06-25 2012-01-04 Helicon Therapeutics, Inc. Altering memory by affecting staufen function
US7642281B2 (en) * 2002-08-07 2010-01-05 Helicon Therapeutics, Inc. Indolone compounds useful to treat cognitive impairment
AU2003258287A1 (en) * 2002-08-19 2004-03-03 Helicon Therapeutics, Inc. Screening methods for cognitive enhancers
AU2006326040B2 (en) * 2005-12-15 2012-02-09 Société des Produits Nestlé S.A. Compositions and methods for preserving brain function
EP2001293B9 (en) * 2006-04-03 2019-04-17 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
SG172602A1 (en) * 2006-05-19 2011-07-28 Helicon Therapeutics Inc Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
GB0611458D0 (en) * 2006-06-09 2006-07-19 Univ Cambridge Tech Assessment of functional status
JP2009541493A (en) * 2006-06-26 2009-11-26 ヘリコン セラピューティクス，インコーポレイテッド Method for modulating neurite outgrowth by use of a galanin-3 receptor antagonist

Also Published As

Publication number Publication date
EP2313098A4 (en) 2011-12-21
IL210696A0 (en) 2011-03-31
SG195572A1 (en) 2013-12-30
MX2011000652A (en) 2011-06-16
IL210696A (en) 2014-12-31
AU2009270697A1 (en) 2010-01-21
CN102143749A (en) 2011-08-03
WO2010009453A1 (en) 2010-01-21
JP2011528667A (en) 2011-11-24
EP2313098A1 (en) 2011-04-27
KR20110049801A (en) 2011-05-12
JP5789511B2 (en) 2015-10-07
CA2730940A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
BRPI0910608A2 (en) methods and systems for evaluating clinical outcomes
BRPI0913924A2 (en) methods and systems for clinical infertility assessment
BRPI0820980A2 (en) Compositions and methods for thiab detection
BRPI0908379A2 (en) systems and methods for custom dentures
IS8948A (en) Methods and systems for individual action plans
BRPI0914034A2 (en) floor cleaning device and floor cleaning method
BRPI0717389A2 (en) STENT ADVANCE DEVICES AND METHODS
BRPI1015922A2 (en) systems and methods for testing analytes
BRPI0813216A2 (en) PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEM.
BRPI0910851A2 (en) methods and systems for harq protocols
BRPI0923760A2 (en) nanostructured articles and methods for manufacturing nanostructured articles
BRPI0818011A2 (en) Method and device for associating objects
BRPI0923159A2 (en) delta-endotoxin gene axmi-150 and methods for its use.
BRPI0907731A2 (en) Plastic stormwater holding chamber and related systems and methods
BRPI0917905A2 (en) memory device and method
BRPI0823036A2 (en) Noise Reduction Device and Noise Reduction Method
BRPI0915492A2 (en) systems and methods for transferring values
BRPI0809737A2 (en) PH MEASUREMENT METHOD AND SYSTEM
BRPI1010694A2 (en) method and device for accessing the relay node
BRPI0918434A2 (en) system and method for assessing structure-born sound.
BRPI0720604A2 (en) DEMINERALIZATION DETECTION COMPOSITION AND METHOD
BRPI0822179A2 (en) Methods and systems for analyzing hard tissues
BRPI0907150A8 (en) microelastography device and method
BRPI0918916A2 (en) memory device for resistance-based memory applications
BRPI0917637A2 (en) method and hardware storage device

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]